维普期刊资源整合服务平台（V6.5）

4577篇 您的检索式：期刊名="Proc AMS"

选中清除导出查看参考文献查看引证文献引用追踪共229页首页上一页第1页下一页末页 /229 跳转

	题名	作者	年代	出处	被引量
1	Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cell in vitro显示文摘	Morland C M Fear J McNab G	1997	Proc Assoc Am Physicians1997，109，：	1
2	Long-term benefit is observed in a phase Ⅲ comparison of sequential vs concurrent chemoradiation for patients with unresected stage Ⅲ NSCLC: RTOG 9410显示文摘	Curran WJ Scott CB Langer CJ	2003	Proc Am Soc Clin Oncol2003，22，：	1
3	ECOG 4599 phase Ⅲ trial of carboplatin and paclitaxel ± bevacizumab: Subset analysis of survival by gender显示文摘	BRAHMER JR GRAY R SCHILLER JH	2006	Proc Am Soc Clin Oncol2006，24，：	1
4	In vitro combination effect of docetaxel (RP56976) with vinca alkaloids on cancer cell- lines显示文摘	Hino H Kobayashi K Hayashihara K	1995	Proc Am Assoc Cancer Res1995，36，：	1
5	A wind erosion equation显示文摘	Wood ruff N P Siddoway F H	1965	Proc Soil Sci Soc Am1965，，29：	1
6	Results of surgery for liver metastases (LM) after neoadjuvant chemotherapy (CT) with irinotecan + infusional fluorouracil/leucovorin ( Iri - FU/LV ) in patients (pts) with colorectal cancer ( CRC ) 显示文摘	Clavero - Fabri MC Mitry E Chidiac J	2003	Proc Am Soc Clin Oncol2003，22，：	1
7	Phase III randomized comparison of gemcitabine and carboplatin(GC) with mitomycin,ifosfamide and cisplatin (MIP) in advanced non - small cell lung cancer( NSCLC ) 显示文摘	Rudd RM Gower NH James LE	2002	Proc Am Soc Clin Oncol2002，21，：	1
8	Neo-adjuvant treatment with erlotinib in squamous cell carcinoma head and neck (SCCHN) patients before surgery provides an opportunity to find predictive factors of response显示文摘	Delord J Thomas F Benlyazid A	2006	Proc Am Soc Clin Oncol2006，24，：	1
9	Mesenchymal progenitor cell research: limitations and recommendations显示文摘	Summer R Fine A	2008	Proc Am Thorac Soc2008，5，6：	1
10	High efficacy but considerable toxicity of campath - 1H consolidation therapy in CLL patients responding to fludarabine - results of a randomized phase Ⅲ trial显示文摘	Ritgen M Jaeger G	2003	Proc Am Soc Clin Oncol2003，22，：	1
11	Pulmonary hypertension and chronic obstructive pulmonary disease : a case for treatment 显示文摘	Higenbottam T	2005	Proc Am Thorac Soc2005，2，：	1
12	Eat dirt:CpG DNA and immunomodulation of asthma显示文摘	Kline J N	2007	Proc Am Thorac Soc2007，4，：	1
13	Matrix Metalloproteases in Ab- errant Fibrotic Tissue Remodeling显示文摘	Annie Pardo Moises Selman	2006	Proc Am Thorac Soc2006，3，：	1
14	Future treatments for chronic obstructive pulmonary dis- ease and its comorbidities 显示文摘	Bames PJ	2008	Proc Am Thorac Soc2008，5，8：	1
15	CA15-3and CEA spikes during chemotherapy for metastatic breast cancer显示文摘	Hayes DF Kiang DT Korzum AH	1998	Proc Am Soc Clin Oncol1998，7，：	1
16	IgM antibodies to ganglio-side GM3 and GD3 induced by active immunization correlated withsurvival in melanoma patients显示文摘	Takahashi T Chang C Morton DL	1995	Proc Am Assoc Cancer Res1995，36，：	1
17	Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912)显示文摘	Boku N Yamamoto S Shirao K		Proc Am Soc Clin Oncol0，25，：	1
18	Letrozole, a new potent, selective aromatase inhibitor superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer previously treated with antiestrogens显示文摘	Marty M Gershanovich M Campos B	1997	Proc AM Soc Clin Oncol1997，16，：	1
19	Overall survival advantage to simultaneous chemotherapy plus the humannized anti-HeR2 monoclonal antibody Herceptine in HER2 overexpressing metastatic breast cancer 显示文摘	Norton L Slamon D Leyland-Jones b	1999	Proc Am Soc Clin Oncol1999，18，：	1
20	Paclitaxel-cisplatin versus teniposide-cisplation in advanced non-small cell lung cancer 显示文摘	Giaccone G Splinter T Postmus P	1996	Proc Am Soc Clin Oncol1996，15，：	1

返回顶部每页显示：

共229页首页上一页第1页下一页末页 /229 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示